Clinical Trial Update: Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated the efficacy and safety of ursodeoxycholic acid for chronic hepatitis C; the study completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2011-11-07